APA (7th ed.) Citation

Shimose, S., Hiraoka, A., Nakano, M., Iwamoto, H., Tanaka, M., Tanaka, T., . . . Torimura, T. (2021). First‐line sorafenib sequential therapy and liver disease etiology for unresectable hepatocellular carcinoma using inverse probability weighting: A multicenter retrospective study. Wiley.

Chicago Style (17th ed.) Citation

Shimose, Shigeo, et al. First‐line Sorafenib Sequential Therapy and Liver Disease Etiology for Unresectable Hepatocellular Carcinoma Using Inverse Probability Weighting: A Multicenter Retrospective Study. Wiley, 2021.

MLA (8th ed.) Citation

Shimose, Shigeo, et al. First‐line Sorafenib Sequential Therapy and Liver Disease Etiology for Unresectable Hepatocellular Carcinoma Using Inverse Probability Weighting: A Multicenter Retrospective Study. Wiley, 2021.